PULM Pulmatrix, Inc.
Healthcare$1.34-2.19%ClosedMarket Cap: $4.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.36
P/S
0.00
EV/EBITDA
-0.34
DCF Value
$1.05
FCF Yield
-95.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-102.1%
ROA
-100.7%
ROIC
-128.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-1.3M | $-1.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-908.0K | $-928.0K | $— | — |
| FY null | $0.00 | NaN% | $-5.2M | $-5.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-866.0K | $-877.0K | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.5M | $-1.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-1.8M | $-1.8M | $— | — |
| Q4 null | $3.0K | -100.0% | $-2.0M | $-2.0M | $— | — |
| FY null | $7.8M | 8.2% | $-9.8M | $-9.6M | $— | — |
| Q3 null | $366.0K | -122.4% | $-2.7M | $-2.6M | $— | — |
| Q2 null | $1.6M | -82.6% | $-5.9M | $-5.8M | $— | — |
| Q1 null | $5.9M | 40.3% | $747.0K | $825.0K | $— | — |
| Q4 2023 | $2.2M | -59.7% | $-2.2M | $-2.1M | $-0.57 | — |